marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Regulus Therapeutics Financial Ratios 2011-2024 | RGLS
Annual Financial Ratios Regulus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.8 | -0.6 | -0.1 | -3.1 | -1.0 | -0.2 | -1.3 | -0.8 | -5.3 | -14.9 | -19.0 | -2.8 | - |
P/S |
- | - | - | 4.9 | 2.7 | 113.8 | 1316.5 | 57.5 | 14.3 | 110.1 | 18.1 | 3.9 | - |
EPS |
1.6 | 1.9 | 3.2 | -0.5 | -1.1 | -5.6 | -1.0 | -1.6 | -1.1 | -1.3 | -0.5 | -2.1 | -85.8 |
EV (Enterprise Value) |
38.5 M | 6.14 M | -44.1 M | 29.1 M | 6.59 M | 28 M | 124 M | 98.3 M | 298 M | 846 M | 367 M | 50 M | 75.2 M |
EBITDA per Share |
-1.63 | -1.84 | -3.19 | -0.391 | -0.921 | -5.1 | -10.8 | -18 | -12.4 | -11.8 | -5.13 | -16.9 | - |
EV/EBITDA |
1.7 | -1.6 | 0.1 | -0.2 | -1.5 | -0.9 | -5.3 | -19.7 | -21.2 | -1.6 | - | ||
PEG |
-0.02 | -0.01 | -0.0 | -0.05 | -0.01 | -0.0 | -0.03 | 0.02 | -0.33 | 0.09 | -0.25 | 0.01 | - |
P/B |
2.5 | 0.5 | 0.0 | 1.9 | 0.9 | -1.4 | 2.7 | 1.2 | 2.4 | 6.4 | 3.8 | 0.8 | - |
P/CF |
-2.0 | -0.7 | -0.1 | -3.9 | -0.9 | -0.2 | -1.6 | -1.2 | -5.8 | -20.7 | -12.2 | -4.8 | - |
ROE % |
-141.77 | -85.08 | -50.60 | -60.44 | -92.89 | 832.06 | -204.18 | -145.94 | -44.93 | -42.93 | -19.97 | -28.04 | - |
ROA % |
-97.68 | -60.63 | -40.62 | -41.83 | -44.18 | -174.42 | -92.41 | -81.30 | -39.51 | -33.05 | -15.17 | -16.82 | - |
ROCE % |
-146.83 | -84.82 | -50.61 | -54.39 | -82.19 | -3650.51 | -155.13 | -93.84 | -42.63 | -32.95 | -15.80 | -13.86 | - |
Current Ratio |
3.2 | 3.5 | 5.1 | 3.2 | 1.9 | 0.7 | 2.0 | 6.3 | 10.6 | 4.7 | 11.3 | 7.7 | - |
DSO |
- | - | - | 18.3 | 61.0 | 131.8 | 1890.9 | 506.5 | 176.2 | 13.0 | 1.5 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Regulus Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.21 | -0.17 | -0.29 | - | -0.4 | -0.37 | -0.42 | - | -0.5 | -0.5 | -0.46 | - | -0.1 | -0.78 | -0.08 | -0.03 | -0.04 | -0.23 | -0.25 | -0.23 | -0.26 | -0.3 | -0.31 | -0.98 | -1.18 | -1.59 | -1.85 | -1.67 | -2.11 | -0.41 | -0.38 | -0.38 | -0.37 | -0.4 | -0.4 | -0.14 | -0.25 | -0.41 | -0.29 | -0.47 | -0.23 | -0.28 | -0.3 | -0.05 | -0.05 | -0.2 | -0.2 | -0.22 | -15.98 | -10.78 | -13.06 | -14.81 | -11.68 | -28.98 | -45.64 |
EBITDA per Share |
- | - | -0.3 | - | - | - | -0.43 | - | -0.51 | -0.49 | -0.45 | - | -0.1 | -0.81 | -0.08 | - | -0.02 | -0.21 | -0.22 | - | -0.2 | -0.24 | -0.22 | - | -0.94 | -1.41 | -1.73 | - | -1.79 | -0.38 | -0.36 | - | -0.33 | -0.38 | -0.4 | - | -0.23 | -0.4 | -0.25 | - | -0.24 | -0.28 | -0.24 | - | -0.05 | -0.11 | -0.15 | - | -0.01 | -0.01 | -0.01 | - | -3.54 | - | - |
ROE % |
-63.00 | -74.49 | -83.87 | -75.16 | -94.19 | -85.54 | -82.04 | -49.81 | -79.55 | -90.26 | -89.51 | -68.30 | -73.38 | -49.50 | -59.81 | -60.44 | -79.81 | -101.05 | -99.41 | -92.89 | 77.83 | 280.41 | 542.01 | 832.05 | 644.74 | 424.31 | 126.41 | -204.18 | -198.86 | -188.72 | -164.97 | -145.94 | -116.06 | -91.73 | -71.07 | -44.93 | -55.90 | -52.84 | -44.96 | -42.93 | -28.20 | -23.10 | -21.89 | -19.97 | -28.99 | -35.83 | -32.15 | -28.04 | -12.11 | -0.43 | 3.75 | 4.86 | 2.52 | - | - |
ROA % |
-53.74 | -59.47 | -64.94 | -56.08 | -56.08 | -48.72 | -46.02 | -37.75 | -44.43 | -64.48 | -63.29 | -47.32 | -50.84 | -34.85 | -41.13 | -41.83 | -49.94 | -58.78 | -52.22 | -44.18 | -63.22 | -87.11 | -124.78 | -174.41 | -162.32 | -145.88 | -124.06 | -92.41 | -93.73 | -92.78 | -85.96 | -81.30 | -66.53 | -56.36 | -50.31 | -39.51 | -47.32 | -43.82 | -35.89 | -33.05 | -21.69 | -17.74 | -16.73 | -15.17 | -20.25 | -23.98 | -20.52 | -16.82 | -14.87 | -11.82 | -9.31 | -4.70 | -2.44 | - | - |
ROCE % |
-66.96 | -78.19 | -87.22 | -77.98 | -97.04 | -87.35 | -82.77 | -49.34 | -78.36 | -88.31 | -89.40 | -68.43 | -72.64 | -47.83 | -54.76 | -50.43 | -75.38 | -96.12 | -94.48 | -61.95 | 106.38 | 299.66 | 550.93 | 662.47 | 618.70 | 406.60 | 118.12 | -160.23 | -194.45 | -184.90 | -162.16 | -110.13 | -120.89 | -97.42 | -76.71 | -38.20 | -47.03 | -45.11 | -37.89 | -26.80 | -29.91 | -24.18 | -19.34 | -14.06 | -19.75 | -22.33 | -21.43 | -13.32 | -10.97 | -2.94 | 1.18 | - | 2.34 | - | - |
Current Ratio |
13.5 | 17.5 | 17.4 | 3.2 | 4.0 | 4.5 | 3.5 | 3.5 | - | 4.5 | 5.2 | 5.1 | 3.1 | 3.9 | 3.1 | 3.2 | 3.2 | 3.2 | 3.2 | 1.9 | 1.9 | 1.9 | 1.9 | 0.8 | 0.8 | 0.8 | 0.8 | 1.8 | 1.8 | 1.8 | 1.8 | 2.3 | 2.3 | 2.3 | 2.3 | 8.3 | 8.3 | 8.3 | 8.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.2 | 4.2 | 4.2 | 4.2 | 2.5 | 2.5 | 2.5 | 2.5 | 1.0 | 1.0 | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.2 | 9.2 | - | 12501.2 | 5784.2 | 5784.2 | 5784.2 | 7.9 | 131.8 | 131.8 | 131.8 | 1011.4 | 1890.9 | 1890.9 | 1890.9 | 5145.5 | 8400.1 | 741.2 | 313.1 | 1089.6 | 84.2 | 490.3 | 238.5 | 111.8 | 5.9 | 23.1 | 34.0 | 9.9 | 1.5 | 19.6 | 25.1 | 1.1 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.2 | 9.2 | - | 12501.2 | 5784.2 | 5784.2 | 5784.2 | 7.9 | 131.8 | 131.8 | 131.8 | 1011.4 | 1890.9 | 1890.9 | 1890.9 | 5145.5 | 8400.1 | 741.2 | 313.1 | 1089.6 | 84.2 | 490.3 | 238.5 | 111.8 | 5.9 | 23.1 | 34.0 | 9.9 | 1.5 | 19.6 | 25.1 | 1.1 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.2 | 9.2 | - | 12501.2 | 5784.2 | 5784.2 | 5784.2 | 7.9 | 131.8 | 131.8 | 131.8 | 1011.4 | 1890.9 | 1890.9 | 1890.9 | 5145.5 | 8400.1 | 741.2 | 313.1 | 1089.6 | 84.2 | 490.3 | 238.5 | 111.8 | 5.9 | 23.1 | 34.0 | 9.9 | 1.5 | 19.6 | 25.1 | 1.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency